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Background
Different inflammatory joint diseases have distinct pat-
terns of bone damage with pronounced erosions in rheu-
matoid arthritis (RA), a combination of bone destruction
and formation in psoriatic arthritis (PsA), and new bone
formation in spondyloarthritis (SpA). Although the
underlying mechanisms remain elusive, blocking of
DKK-1 reverses the bone-destructive pattern to a bone-
forming pattern in experimental arthritis.
Aim
In order to delineate the role of DKK-1 in arthritis, we
analyzed the regulation of DKK-1 expression in the
inflamed peripheral joint of different types of inflamma-
tory arthritis ex-vivo and in fibroblast-like synoviocyte
(FLS) cultures in vitro.
Patients and methods
IL-6, DKK-1, TNF, and IL-1 beta levels in synovial fluid
(SF) and synovial FLS lines were determined by ELISA.
DKK-1 serum levels were assessed before and after
IL-6R blockade in RA patients.
Results
SF DKK-1 levels were similar between 4 disease groups
with a striking variability within each cohort. As DKK-1
production is strongly upregulated by TNF, we explored
this inter-individual variability by correlating DKK-1
levels with pro-inflammatory cytokines levels. TNF and
IL-1 beta levels were significantly higher in RA than
SpA SF and did not correlate with DKK-1. In contrast,
there was a striking inverse correlation between DKK-1
and IL-6 in both RA and SpA. Consistent with these
data, in vitro DKK-1 production by FLS was strongly
induced by TNF but clearly suppressed by IL-6 in dose-
dependent manner. Preliminary data suggest that this
regulation of DKK-1 by IL-6 is also relevant in vivo as
treatment with the anti-IL-6 R antibody, tocilizumab,
induced a transient upregulation of DKK-1 serum levels
in RA patients.
Conclusions
DKK-1 is abundantly expressed in the inflamed joint of
both destructive and remodelling forms of arthritis. How-
ever, DKK-1 production by FLS is differentially regulated
by TNF and IL-6. The relative balance between these
factors in the arthritic joints may determine the pattern
of inflammation-induced tissue remodelling.
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